midterm 3 Final 203C

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/188

encourage image

There's no tags or description

Looks like no tags are added yet.

189 Terms

1
New cards

Innate immunity

1st-line Bodily defense that is broadly protective against a variety of threats

2
New cards

Examples of innate immunity

Skin

Gastric acid

Mucous secretions

Cilia

Tears

3
New cards

Types of blood cells

Neutrophils

Lymphocytes

Monocytes

Eosinophils

Basophils

4
New cards

Neutrophils

1st line defense against bacterial and fungal infection

5
New cards

Lymphocytes

Lysis of infected self cell, antivirals (viral illness)

6
New cards

Monocytes

2nd line defense in bacterial infection; targets infection and some cancers

7
New cards

Eosinophils

parasitic infections, hypersensitivity; allergic runs, asthma, parasites, auto-immune conditions

8
New cards

Basophils

allergic response, anti-infective; some cancers

9
New cards

Inflammatory molecules in innate immunity

interferons

prostaglandins

histamine

anti-microbial proteins

ferritin

complement

10
New cards

True or false: inflammatory molecules in innate immune system cause increased vasodilation and vascular permeability

true

11
New cards

Increased vasodilation leads to

increased blood flow to site of injury

12
New cards

Increased vascular permeability leads to

increased WBC penetration to site of injury

13
New cards

Universal signs of inflammation

Fever

Redness

Pain

Swelling

Heat

14
New cards

Adaptive immunity

specificity against one particular threat and long-lasting memory for future exposure.

15
New cards

What two things does adaptive immunity consists of?

T cells and B cells

16
New cards
17
New cards

SLE

systemic lupus erythematosus

systemic autoimmune disease characterized by antibody production and cytokine overproduction

18
New cards

SLE MOA

autoreacive B cells produce antibodies against the body’s own components such as dsDNA

Autoreactive T cells contribute to immune activation and inflammation

Cytokines (inteferons/interlaukins) amplify the inflammatory response

19
New cards

SLE consequences

immune dysregulation, inflammation, and tissue damage leading to symptoms affecting multiple organs, including the skin, joints, kidneys, nervous system, and heart

20
New cards

Anti-DsDNA

lupus nephritis (kidney)

21
New cards

anti-NMDA

CNS complications

22
New cards

Antiphospholipids antibodies (aPL)

Forms a hypercoagulable state → blood more likely to form clots

Thrombosis and pregnancy complications (obstetrics)

23
New cards

APS

antiphospholpipid antibodies syndrome

persistent aPL positivity + clinical manifestations such as thrombosis or pregnancy losses

24
New cards

Low C3/C4

immune dys-regulation → autoantibody production → immune complex formation → complement activation → increased complement consumption → C3/C4 decrease

25
New cards

SLE risk factors

age - young

sex - Female

race - young black women/other non-white

environmental exposures - cigareete, epstein-Barr virus, heavy metals

family history

26
New cards

Greatest mortality risk SLE

men or individuals with adult-onset disease

27
New cards

4 major contrbutors to mortality in SLE

cardiovascular disease

infection

renal complications

malignancies

28
New cards

3 APL antibodies

anticardiolipin

anti-B2GPI

Lupus anticoagulant

29
New cards

Five major presentations of SLE

musculoskeletal lupus

cutaneous lupus

antiphospholipid syndrome

lupus nephritis

CNS lupus

30
New cards

True: lupus arthritis always causes joint destruction

false: usually lupus arthritis does not cause joint destruction while rheumatoid arthritis does

31
New cards

Musculoskeletal lupus

lupus arthritis

sxs: myalgias, arthralgias, arthritis, muscle weakness, chronic fatigue

~90% w/ SLE exp these sxs

32
New cards

cutaneous lupus

Malar butterfly rash; rash across cheeks and bridge of the nose

Photosensitivity: skin sxs that worsen with sunlight exposure

Painless oral ulcers: sores inside the mouth that may go unnoticed because the dont hurt

Alopecia: hair loss

33
New cards

lupus nephritis

manifestation of advanced lupus

When lupus causes inflammation and age to these structures blood and proteins can leak into the urine.

sx: hematuria (blood in urine), proteinuria, increased SCr, increased BUN

34
New cards

true of false: lupus nephritis is diagnosed via sxs

false: lupus nephritis diagnosed officially via kidney biopsy

35
New cards

CNS lupus

manifestation of advanced SLE

anti-NMDA antibodies → CNS complications

sx: HAs, seizures, delirium, mood changes, psychosis

36
New cards

Miscellaneous SLE symptoms

fever without infection (inflammation from lupus itself can cause fever)

weight loss

pancytopenia (Decreased red blood cells, white blood cells, and platelets)

vasculitis (inflammation of blood vessels)

Raynaud’s phenomenon (reduced blood flow to the fingers or toes often triggered by cold or stress)

37
New cards

3 specific criteria of SLE diagnosis according to 2019 EULAR/ACR classification framework

ANA positivity >/= 1:80

Clinical findings at least 1 clinical criterion

EULAR/ACR weighted score >/= 10 points

38
New cards

True or false: having at least 2 of the any 3 criteria classifications checked off allows for SLE diagnosis

False: ANA is an entry criterion for this classification system but a positive alone does not qualify for SLE. We need all three to be diagnosed with SLE

39
New cards

SLE: Non-biologics therapy

Hydroxychloroquine

corticosteroids

40
New cards

SLE: non-biologic immunosuppressants

methotrexate

azathioprine

mycophenolate

cyclosporine

cyclosphamide

voclosporin

41
New cards

SLE biologics

Belimumab

rituximab

anifrolumab

42
New cards

Hydroxychloroquine

Plaquenil

inhibits toll-like receptors (TLRs) and decreases T-cell activation/cytokine production which ultimately reduced lupus-related inflammation

cornerstone of SLE treatment → consider in all pts unless contraindicated

1st line for low-disease activity RA

ADR: N/V, abdominal pain, rash, retinal toxicity

monitoring: eye monitoring - baseline exam and q5yrs after initiation

43
New cards

hydroxychloroquine dosing for RA

200 mg BID or 400 mg QD

44
New cards

Hydrochloroquine dosing for lupus

5mg/kg/day

45
New cards

How long does it take for hydrochloroquine to reach full medical benefit in lupus

3-6 months

46
New cards

True or false: hydroxychloroquine can cause irreversible eye damage

True; retinal toxicity may lead to irreversible damage.

47
New cards

If hydroxychloroquine is for long term use w/o immediate relief, what can be used for acute flare relief

corticosteroids

48
New cards

Corticosteroids: Risk mitigation

bone protection - pts taking prednisone >/=2.5mg/d should receive calcium and vitamin D supplementation

surgery - pts taking chronic corticosteroidss who undergo surgery may require stress-dose steroids

discontinuation - never abruptly d/c chronic corticosteroids therapy

49
New cards

Corticosteroids: acute adverse effects

fluid retention

electrolyte disturbances

increased blood pressure

hyperglycemia

mood changes, insomnia, psychosis

50
New cards

Corticosteroids: chronic effects

immunosuppression

skin thinning and striae

weight gain and atypical fat distribution

osteoporosis

glaucoma

51
New cards

Belimumab

Benlysta

targets B-cell pathway: blocks B-lymphocyte stimulator (BLyS)/BAFF a protein that supports B-cell survival → decreases autoantibody production

dose: IV 10 mg/kg every 4 weeks; SubQ 200 mg 1x/week

Steroid-sparing effect: reduces the need for corticosteroids in treating lupus by helping improve disease control

ADR: infusion rxn, mood disorders, infections

52
New cards

Belimumab and lupus nephritis

Pts with this disease requires at least 2 IV doses before switching to subQ

53
New cards

Anifrolumab

Saphnelo

Type I interferon inhibitor → interferons are cytokines involved in immune signaling which causes inflammation.

most useful in pts with cutaneous lupus → prominent skin manifestations OR steroid-sparing pts who require chronic corticosteroids to control disease activity

Dose: 400 mg IV q4weeks ~300 mg is the FDA approved tho 😛

ADR: infusion rxn, respiratory infection, herpes zoster (increased risk of shingles)

54
New cards

Voclosporin

lupkynis

calcineurin inhibitor → calcineurin activates T-cells promotes production of IL-2, inhibiting it reduces inflammation

for pts with lupus nephritis already receiving mycophenolate and glucocorticoids; its an addition

C/I initiation in pt eGFR <45; BP >165/105

ADR: diarrhea, eGFR decline, HTN, migraines

55
New cards

DDI for voclosporin

CYP3A4 inhibitors/Grapefruit → increases exposure which could be devastating in pts with lupus nephritis

56
New cards

Cyclophosphamide

Cytoxan

alkylating agent that damages DNA to prevent cell proliferation including immune cells responsible for lupus inflammation

last-line treatment for SLE due to substantial immunosuppression and toxicity

C/I: pregnancy

ADR: hemorrhagic cystitis (inflammation/bleeding of the bladder, myelosuppression (reduced production of blood cells in bone marrow), infertility (potential reproductive toxicity)

57
New cards

What can be co-admin with cyclophosphamide to decrease risk of hemorrhagic cystitis

mesna

58
New cards

Rituximab

Rituxan

monoclonal antibody that targets CD20 a protein expressed on the surface of many B-cells to deplete B-cells and reduce autoimmune activity in lupus.

dosing based on body surface area (m2) not kg

ADR: infusion rxn, infection activation/reactivation

premedication before infusion to reduce infusion rxn and screen for TB/hepatitis before initiating

59
New cards

Methotrexate

MTX

antimetabolite that helps decrease inflammation and control symptoms such as lupus-related arthritis

Considered in pts with uncontrolled mucoskeletal lupus → inflammatory joint manifestations

1st line for mod-high disease activity RA

C/I: pregnancy

ADR: elevated LFTs, stomatitis (ulcerations/inflammation in oral mucosa), teratogenic

Should be given with folic acid to reduce side effects such as stomatitis and gastrointestinal toxicity; should screen for hep B/C before starting

60
New cards

Methotrexate dosing for RA

7.5-20 mg weekly

for initial can break down 7.5 mg to 2.5 mg for 3 doses in 1 day

61
New cards

Methotrexate dosing for Lupus

15-25 mg weekly

62
New cards
63
New cards

Azathioprine

Imuran

antimetabolite that inhibits purine synthesis to reduce T and B cell proliferation and reducing immune response

uncontrolled musculoskeletal lupus and pregnant

daily dosing

ADR: myelosuppression (reduced production of red blood cells), hepatotoxicity (LFTs elevation)

64
New cards

Mycophenolate

cellcept, myfortic; MMF/Cellcept (1 g BID) and myfortic (720 mg BID) not interchangeable diff mg dosages

antimetabolite immunosuppressant that interferes with purine synthesis by inhibiting inosine monophosphate dehydrogenase (IMPDH) which prevents T/B cell proliferation and suppresses immune response

Useful in lupus nephritis induction therapy → initial more intensive treatment phase intended to rapidly control active disease “save the kidney, STAT”

ADR: myelosuppression, GI distress, teratogenicity (fetal harm)

65
New cards

SLE treatment pathway

hydroxychloroquine, UV protection, smoking cessation, medication review for potential drug-induced lupus, glucocorticoids depending on disease severity

and use of immunosuppressants like Methotrexate, Azathioprine, or Mycophenolate as needed.

66
New cards

positive antiphospholipid antibodies w/ no hx of thrombosis

consider aspirin

67
New cards

positive antiphospholipid antibodies w/ hx of thrombosis

warfarin

68
New cards

Non-pharm SLE treatment

UV protection

Tobacco avoidance

Exercise

69
New cards

Fertility and SLE

avoid estrogen-contiaing contraceptives in pts with antiphospholipid antibodies → increased risk of thrombosis

Copper IUDs are effective however increase bleeding risk

Progestin-only contraceptives are recommended as safer alternatives for women with SLE → avoids estrogen-related thrombotic concerns

70
New cards

Pregnancy and SLE

high risk pregnancy complications such as preeclampsia, fetal growth restriction, and increased risk of miscarriage due to lupus

hydroxychloroquine (lupus) and low-dose aspirin (preeclampsia)

71
New cards

Drugs that induce lupus

procainamide → high

hydralazine → high

minocycline

isoniazid

TNF inhibitors

72
New cards

How to recognize drug-induced lupus

pt starts med → one month passes → lupus-like sxs → med d/c → sxs improve

73
New cards

SLE Monitoring

monitor sxs and disease activity q4mos → rash, joint inflammation, mood changes, etc

Monitor markers (ANA, autoantibodies, ESR, CRP) q4-12mos

Monitor adherence hydroxychloroquine every encounter

Monitor body weight every encounter

Monitor hydroxychloroquine retinal toxicity q5yrs after initial baseline dilated eye exam

74
New cards

Gout

inflammatory response to monosodium urate deposition in joints

75
New cards

Does purine increase or decrease uric acid

Increase: purine metabolism leads to increased uric acid levels in the blood, potentially causing gout.

76
New cards

Hyperuricemia

uric cid levels >6.8

77
New cards

Uric over-production causes

physiologic purines derived from normal metabolism

dietary intake

tumor lysis sundrome

rare enzyme abnormalities

78
New cards

Uric acid under-excretion

renally eliminated → kidney dysfunction leads to increased serum uric acid

79
New cards

Drug-induced gout

increased purine production: chemotherapy causing tumor lysis, ethanol

Decreased uric acid excretion: loop/thiazide diuretic, calcineurin inhibitors, low-dose salicylate, pyrazinamide, levodopa, insulin, ethanol

80
New cards

True or false: gout and hyperuricemia are the same thing/interchangebale

False; gout is a form of arthritis caused by the accumulation of uric acid crystals causing joint pain, arthritis, inflammation, and joint destruction. Hyperuricemia refers to elevated levels of uric acid in the blood (>6.8), which may not always result in gout.

81
New cards

Acute gout attack

acute onset

lower extremity joint pain

pain frequently begins overnight

generally resolve after 7-14 days even without treatment

may be provoked by alcohol intake, initiation if gout causing drug, purine overconsumption, rapid lowering of serum uric acid

82
New cards

Which body part greatly affected by cut gout atttack

the great toe; often first joint to experience pain/swelling

83
New cards

How is acute gout attack defined?

athrocentesis + synovial fluid analysis with MSU crystals

AND

acute painful symptoms

84
New cards

inter-critical gout

an asymptomatic period between gout attacks

may last years

periods may shorten in progressively worsening disease

85
New cards

Tophaceous gout

large urate crystal deposition in joints

joint destruction

86
New cards

Gout nephropathy

nephrolithasis with urate crystals

acute CKD

87
New cards

Diagnosis: GOUT

definitive diagnosis: synovial fluid aspirate with monosodium urate monohydrate crystals

Clinical diagnosis: recurrent monoarticular joint pain + inflammation + erythema + hyperuricemia

88
New cards

Whats the acute gout diagnosis rule?

not recommended for or against by contemporary guidelines

can be useful to gauge level of concern when clinical picture unclear

89
New cards

Colchicine

MOA: anti-mitotic prevents immune system infiltration into joints and reducing inflammation and pain

ADRs: N/V, diarrhea (GI upset)

Renally eliminated

90
New cards

Colchicine dosing CrCl > 30

Day 1: 1.2 mg x 1 dose + 0.6 mg 1 hr later

Day 2: 0.6 mg BID until flare resolves

Prophylaxis: 0.6 mg BID daily

91
New cards

Colchicine dosing CrCl < 30

1.2 mg x 1 dose + 0.6 mg 1 hr later

Prophylaxis: 0.3 mg QD-daily

92
New cards

Colchicine dosing dialysis

0.3-0.6 mg x 1 dose

Prophylaxis: 0.3 mg 2x/wk

93
New cards

Other gout anti-inflammtories

NSAIDs: indomethacin, naproxen, sulindac

Corticosteroida: prednsone, intra-articular triamcinolone

94
New cards

Gout - NSAIDs

avoid in elderly

Caution in pts with hx. HF, PUD/GI risk, renal dysfunction

95
New cards

Gout - Corticosteroids

caution w/ hx, of diabetes

IA triamcinolone use of confined to 1-2 joints

96
New cards

Xanthine oxidase

urate lowering therapy

allopurinol: less effectuve but cheaper and no CV risk

Febuxostat: more effective than allopurinol but pricier and higher CV risk

97
New cards

Allopurinol

Zyloprim

intial: 100 mg ; eGFR <60 50 mg

Maintenance: 100-800 mg QD

ADR: urticaria, Gi upset, HAs

HLA-B*5801 screening recommended in those of East Asian, African descent

98
New cards

Uricosurics

urate lowering therapy

Probenacib only available agent in the US

CrCl < 50 → decreased efficacy

ADRs: diuresis, nephrolithiasis, icovonveient pill burden, DDIs

C/I in pts with hx of kidney stones

PTP: stay well-hydrated

99
New cards

Pegloticase

Urate lowering therapy

8 mg IV over 2 hours q2wks

ADRs: infusion rxns, wallet toxicity, decreased effectiveness over time, HF exacerbations

Obtain uric acid levels prior to every infusion; if <6 hold dose

Pre-medicate w/ MTX + daily FA x 4 weeks; use anti-histaminess + corticosteroid during infusion

Reserved for severe gout

100
New cards

Which ARB has a benefit for hyperuricemia

losartan